"Loading Stock Price & Valuation Data ..."
Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to SERA. [ FAQ on what and how to ask] For non-SERA questions, click the logo in the upper-right corner to return to the main page and ask there.
CEO:Ms. Zhenya Lindgardt M.B.A.
Headquarter: 2749 East Parleys Way, Suite 200, Salt Lake City, UT, United States, 84109
Industry: Diagnostics & Research, Investment Track: -, Employees: 71
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy related conditions, such as time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
My Watchlist
